Perfil
Douglas Maffei is currently the Vice President-Investor Relations at Seagen Inc. He previously worked as a Senior Director-Investor Relations at Gilead Sciences, Inc.
Cargos activos de Douglas Maffei
| Empresas | Cargo | Inicio |
|---|---|---|
| SEAGEN INC. | Investor Relations Contact | - |
Antiguos cargos conocidos de Douglas Maffei.
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Investor Relations Contact | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Douglas Maffei
